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The active Al peptide of cholera toxin was linked by a disulphide bond to the lectin of Wisteriafloribunda. 
The resulting conjugate activated the adenylate cyclase of intact U937 or KS62 cells at the same 
concentrations as native toxin did, but to a greater extent. Activation was inhibited by N-acetyl-D- 
galactosamine or by antisera to the lectin or peptide. The characteristic lag phase between addition of toxin 
to cells and activation of cyclase was not found with the conjugate or with free Al peptide. 
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1. INTRODUCTION 
The active Al peptide of cholera toxin (review 
[l]) is transported into the cell following interac- 
tion between the B subunits of the toxin and 
ganglioside GM1 in the outer membrane. It then 
catalyses the ADP-ribosylation of an intracellular 
component of the adenylate cyclase complex. 
The active component of several other toxins 
(e.g., diphtheria toxin, ricin) has been introduced 
into cells by coupling it to a protein not the normal 
binding component of the toxin but also capable of 
binding to cells (see [2]). This paper shows that an 
artificial conjugate of the Al peptide with the lec- 
tin of Wisteria floribunda (which binds to non- 
reducing a-linked N-acetyl-D-galactose residues on 
the outside of many cells [3,4]) could activate the 
adenylate cyclase of intact cells. 
2. EXPERIMENTAL 
Al peptide (a kind gift from Dr J. Tayot of the 
Institut Merieux) was purified to homogeneity on 
Sephadex G-75 in 0.1 M glycine-HCl, 6.5 M urea, 
5 mM dithiothreitol, pH 3.2 [5]. W. floribunda 
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lectin was from E.Y. Laboratories, CA. Both pro- 
teins have free sulphydryl groups, and were 
hybridized by oxidation, essentially as in [6], and 
the concentration of the products determined from 
the intensity of staining in polyacrylamide gels. 
Cells were kindly grown by Dr Veronica van 
Heyningen in a modified RPM11640 medium (Gib- 
co, Scotland). They were centrifuged at 200 x g for 
3 min, resuspended in 0.1 M sodium phosphate, 
0.15 M NaCl (pH 7.0), and 50-~1 aliquots (about 
IO6 cells) prepared. To these were added 5 ~1 of 
solution of toxin, conjugate of peptide; and the 
mixture was incubated at 2O”C, normally for 2 h. 
One ml of the phosphate buffer was added and the 
tubes were agitated and centrifuged for 15 s in a 
Beckman microfuge. After washing the cells once, 
they were cooled to -70°C for lysis. The lysed 
cells were incubated with 40~1 assay medium 
(0.47 mM [2,8-3H]ATP (1.5 MBq/ml, Amer- 
sham), 8.4 mM MgClz, 1.56 mM cyclic AMP, 
1.56 mM dithiothreitol, 20 mM phosphocreatine, 
1 mg/ml creatine kinase and 47 mM 3-(N- 
morpholino)propanesulphonic acid, adjusted if 
necessary to pH 8.8 with NaOH) for 45 min at 
37°C and the cyclic AMP produced assayed as in 
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3. RESULTS 
Polyacrylamide gel electrophoresis in sodium 
dodecyl sulphate under reducing conditions of the 
product of the oxidation of Al peptide and lectin 
showed small residual amounts of these two pro- 
teins and of their dimers together with another 
protein (MI -54000), usually about 80% of the 
total protein and presumably the desired con- 
jugate. A sample of this conjugate was eluted from 
a parallel gel and electrophoresed again in the 
presence of 2-mercaptoethanol: the two monomers 
were released. Furthermore, transfer of a similar 
gel by ‘blotting’ to nitrocellulose followed by treat- 
ment of the blot with antisera to each monomer [8] 
showed that the monomers reacted only with the 
specific antisera, but the conjugate reacted with 
both. These experiments howed that a hybrid pro- 
tein had been prepared. Attempts to purify it were 
not successful, and the following experiments 
therefore use the unpurified solution. 
3.1. Activity 
Fig.1 shows the response of intact U937 cells 
(derived from a histiocytic lymphoma [9]) to 
various concentrations of toxin, conjugate, and 
free peptide. The conjugate activated the cyclase at 
a 2 lOO-fold lower concentration than the free pep- 
tide did (so that the activity cannot have been due 
to contaminating free peptide). 
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Fig.1. Dose response curves for the activation of 
adenylate cyclase in U937 cells. Cells were incubated 
with different concentrations of whole toxin (A), 
conjugate (0) and Al peptide (0) and the intracellular 
activity of adenylate cyclase then measured as described 
in the text. 
The activity of the conjugate (at lo-’ M) was in- 
hibited almost totally by preincubation with an- 
tisera to the lectin, Al peptide or toxin or with N- 
acetylgalactosamine (which binds to the lectin bin- 
ding site [3,4]). Preincubating the cells with 
ganglioside GM1 did not increase the response to 
toxin or conjugate, but the action of toxin and 
conjugate (but not free peptide) was inhibited if 
these proteins were preincubated with ganglioside. 
Such inhibition is always found with native toxin 
[lo] and is presumably also found with the con- 
jugate because of the substituted N- 
acetylgalactosamine r sidue in the ganglioside. 
A characteristic of the action of the toxin on 
whole cells is that there is a lag phase (whose dura- 
tion varies from about 15 to 90 min depending on 
the type of cell) between the initial binding to the 
cell surface and the activation of adenylate cyclase. 
Fig.2 shows that this was true of the action of toxin 
on the U937 cells, but not of the conjugate or of 
the free peptide, which both showed no lag phase. 
Similar experiments howed comparable activity 
of the conjugate with intact K562 cells ([ 111, deriv- 
ed from a myeloid leukaemia) although free pep- 
tide was inactive with these cells. However, neither 
the conjugate nor the peptide produced a signifi- 
cant response in an Epstein-Barr virus transformed 
B-cell line (MST), although these cells did respond 
weakly to toxin. 
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Fig.2. Time course of the activation of adenylate cyclase 
in U937 cells. Cells were incubated with whole toxin (A, 
lo-’ M), conjugate (0, 6 x 10m7 M) or Al peptide (0, 
2 x lo-’ M) for various times and the intracellular 
activity of adenylate cyclase was then measured as 
described in the text. 
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4. DISCUSSION 
The hybrid protein between the Al peptide of 
cholera toxin and the lectin of W. floribunda ac- 
tivates the adenylate cyclase of U937 cells more ef- 
fectively than toxin does. This activation cannot be 
due to contaminating free peptide or native toxin, 
or to activity with lysed cells, since the hybrid is at 
least loo-times more active than the peptide even 
with U937 cells, and 20yM peptide (the highest 
concentration achievable) was inactive with the 
K562 cells. Furthermore both antisera to the lectin 
and inhibitors of its binding (N- 
acetylgalactosamine) inhibited the action of the 
hybrid, showing that the lectin component played 
an essential role. 
When native toxin interacts with a cell, the Al 
peptide is delivered to the interior following the in- 
teraction of the B subunits with the ganglioside. 
When the conjugate interacts with a cell this 
delivery is mediated by the interaction of a dif- 
ferent protein, presumably with a different recep- 
tor. This shows that the entry does not involve any 
specific interaction between the B subunits and 
ganglioside: rather, some sort of binding is needed, 
but it does not matter which. This supports the 
idea [lo] that the entry of Al may be a com- 
paratively non-specific process involving random 
crossing of the hydrophobic membrane and argues 
against theories in which dissolving the B subunits 
in the membrane play a prominent part. Such 
theories are, in any event, made less likely by the 
observation [12] that Al peptide, but not the B 
subunits, can dissolve in the membrane. If the 
main function of the binding of the B subunits to 
the ganglioside is simply to increase the local con- 
centration of the toxin (and hence of the peptide) 
at the cell surface, then binding of any ligand to 
any receptor will do. 
It is not clear from these experiments at what 
stage the disulphide bond linking the peptide and 
the lectin is reduced. Such a reduction would nor- 
mally occur quite easily at the redox potential in- 
side the cell and might or might not be enzyme 
catalysed [13]. A disulphide bond between the Al 
and A2 peptides is similarly reduced when native 
toxin acts on cells. It is also possible that the Al 
peptide can protrude through the membrane while 
remaining bound to lectin outside. 
The lack of lag phase with the conjugate may 
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reflect easier release of the Al peptide from the 
conjugate than from the toxin. There is evidence 
(e.g. [14]) that the lag with toxin may be due at 
least partly to the time taken to generate free Al. 
If this is true, it would also account for the observ- 
ed lack of lag with purified Al. 
The ability to make this hybrid of cholera toxin 
suggests that other similar hybrids with binding 
components of different specificity could probably 
also be made, and would be found to be active. 
This raises the possibility of using specific binding 
protein that would make it possible to produce a 
conjugate that powerfully activated adenylate 
cyclase in only one particular organ or type of cell. 
This could be useful pharmacologically. 
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